Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC)

CUSIP: 359616109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
66,594,760
Total 13F shares
56,394,454
Share change
+1,107,780
Total reported value
$250,394,156
Put/Call ratio
27%
Price per share
$4.44
Number of holders
79
Value change
+$9,019,379
Number of buys
31
Number of sells
47

Security key

359616109

Report period

Q3 2023

Institutions

79

Top holders

10

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
17%
11,609,704
$38,312,023 30 Jun 2023
13F
RTW INVESTMENTS, LP
13F
Company
9.1%
6,064,123
$20,011,606 30 Jun 2023
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
8.6%
5,718,881
$18,872,307 30 Jun 2023
13F
FMR LLC
13F
Company
8.3%
5,553,740
$18,327,342 30 Jun 2023
13F
COWEN AND COMPANY, LLC
13F
Company
4.7%
3,116,996
$10,286,086 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
3.9%
2,626,029
$8,665,895 30 Jun 2023
13F
TRV GP IV, LLC
13F
Company
3.5%
2,343,154
$7,732,408 30 Jun 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.5%
2,306,422
$7,611,193 30 Jun 2023
13F
Point72 Asset Management, L.P.
13F
Company
2.9%
1,899,968
$6,269,895 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
2.3%
1,514,425
$4,997,603 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
2.3%
1,504,639
$4,965,309 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
1.7%
1,103,874
$3,642,785 30 Jun 2023
13F
Rock Springs Capital Management LP
13F
Company
1.1%
727,673
$2,401,321 30 Jun 2023
13F
Simplify Asset Management Inc.
13F
Company
1%
696,296
$2,297,777 30 Jun 2023
13F
Woodline Partners LP
13F
Company
0.9%
596,695
$1,969,094 30 Jun 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.89%
595,300
$1,964,490 30 Jun 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.87%
577,866
$1,906,958 30 Jun 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.86%
574,857
$1,897,028 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.85%
565,809
$1,867,169 30 Jun 2023
13F
Vivo Capital, LLC
13F
Company
0.83%
550,000
$1,815,000 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.71%
475,335
$1,568,443 30 Jun 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.58%
387,732
$1,279,516 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.52%
344,810
$1,138,000 30 Jun 2023
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.51%
341,972
$1,129,000 30 Jun 2023
13F
BESSEMER GROUP INC
13F
Company
0.43%
286,988
$947,000 30 Jun 2023
13F
Tekla Capital Management LLC
13F
Company
0.39%
256,888
$847,730 30 Jun 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.37%
247,228
$815,853 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.31%
205,947
$679,625 30 Jun 2023
13F
Alyeska Investment Group, L.P.
13F
Company
0.3%
202,148
$667,088 30 Jun 2023
13F
RBF Capital, LLC
13F
Company
0.23%
154,100
$508,530 30 Jun 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
0.22%
146,222
$482,533 30 Jun 2023
13F
BARCLAYS PLC
13F
Company
0.22%
144,983
$478,444 30 Jun 2023
13F
Opaleye Management Inc.
13F
Company
0.22%
143,600
$473,880 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.22%
143,427
$473,309 30 Jun 2023
13F
FIDUCIARY TRUST CO
13F
Company
0.21%
136,555
$450,632 30 Jun 2023
13F
Acuitas Investments, LLC
13F
Company
0.2%
134,815
$444,890 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.2%
132,238
$436,385 30 Jun 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
126,500
$417,450 30 Jun 2023
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.18%
117,000
$386,100 30 Jun 2023
13F
Squarepoint Ops LLC
13F
Company
0.15%
100,791
$332,610 30 Jun 2023
13F
XTX Topco Ltd
13F
Company
0.12%
83,166
$274,448 30 Jun 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.1%
66,293
$218,766 30 Jun 2023
13F
Bank of New York Mellon Corp
13F
Company
0.09%
62,322
$205,663 30 Jun 2023
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.09%
61,587
$203,237 30 Jun 2023
13F
Verition Fund Management LLC
13F
Company
0.09%
59,549
$196,512 30 Jun 2023
13F
MYDA Advisors LLC
13F
Company
0.08%
50,000
$165,000 30 Jun 2023
13F
Ergoteles LLC
13F
Company
0.06%
40,800
$134,640 30 Jun 2023
13F
Laurion Capital Management LP
13F
Company
0.05%
33,645
$111,029 30 Jun 2023
13F
MIRABELLA FINANCIAL SERVICES LLP
13F
Company
0.05%
32,760
$108,108 30 Jun 2023
13F
Middle East Fze Point72
13F
Individual
0.05%
32,145
$106,078 30 Jun 2023
13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) as of Q3 2023

As of 30 Sep 2023, Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,394,454 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, RTW INVESTMENTS, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., TRV GP IV, LLC, BlackRock Inc., and Jefferies Financial Group Inc.. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
85
Q3 2023 holders
79
Holder diff
-6
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .